Key result
The provided text consists only of the journal masthead and editorial board information, containing no clinical study data.
Why the study?
Does anti-Xa activity assay provide better correlation with apixaban plasma concentrations compared to PT/INR assay in patients with VTE?
Does anti-Xa activity assay provide better correlation with apixaban plasma concentrations compared to PT/INR assay in patients with VTE?
Anti-Xa activity assays are preferable to PT/INR assays for measuring plasma concentrations of direct factor Xa inhibitors like apixaban due to stronger correlation and less variability.
No takes yet. Share an insight, caveat, or question.
No data provided on assay performance; leaves open optimal monitoring for apixaban in VTE.
Wang et al. (2010) studied this question. The provided text consists only of the journal masthead and editorial board information, containing no clinical study data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: